We found that the CXCR4 inhibitor AMD 3100 reduces wound-promoted tumor growth without significantly affecting tumor growth in unwounded animals, strongly suggesting that wound-derived SDF-1α, one of the splice variants of SDF-1, increases tumor growth. Here, CXCL12 is linked to neoplasm.